novo nordisk glp-1 receptor agonist Administration Anounces Landmark Pricing Agreement with Eli Lilly and Novo Nordisk said on Tuesday

Adapting to these market shifts, Nestl is launching Vital Pursuit, a new line of frozen food products specifically for consumers on weight loss medications like Ozempic and Wegovy

Each mark represents one unit

Brand-name options typically cost $900-$1,350 per month without insurance, while compounded alternatives range from $196-$599 monthly

Da Silva LN, Cabaleiro A, Novoa E, Riobello C, Knerr PJ, He Y, Esquinas-Romn EM, Gonzlez-Garca I, Prevot V, Schwaninger M, Dieguez C, Lpez M, Mller TD, Varela-Rey M, Douros JD, Nogueiras R

Wegovy is specifically approved for chronic weight management, while Ozempic is primarily used for managing type 2 diabetes (though it may be prescribed off-label for weight loss)

Compared to other antidiabetic medications, the use of GLP-1RAs has not been associated with an increased risk of lung cancer [48]